Centr Georges Francois Leclerc — Clinical Trial Site

351 Registered trials

158 Currently recruiting

Organisation

Centr Georges Francois Leclerc

Location

Dijon, France

Identifier

ORG-100011048

Address

1 Rue Professeur Marion, 21079, France

Departments

#1000:Medical Oncology
#98325006:service d'oncologie médicale
1203: Oncologie Medicale
1207: Oncologie Medicale
1502 Medical Oncology
21
2302: Oncologie Medicale
2302:Oncologie Medicale
2303: Oncologie Medicale
3104: Oncologie Medicale
3105: Oncologie Medicale
33009: Oncologie Medicale
403 : Medical Oncology
Centre de Recherche Clinique
Chirurgie Digestive et Hépato-biliaire
chirurgie idgestive
Côte d'or
CRC – UF Oncologie
Departement d Oncologie Medicale
Département d'oncologie médicale
Département d’oncologie médicale
Département de dermatologie
Departement de Medecine Oncologique
Department de radiotherapie
digestif
digestive oncology
Digestive Oncology and Neuro-Oncology
Digestive Oncology Department
Digestive surgery
Dijon
Early Phase Unit - Medical Oncology
Early Phase unit_Medical Oncology Department
Gynecological surgery
Hépato-Gastro-Entérologie
Médecin nucléaire
MEDECINE INTERNE
Medecine nucleaire
Medical oncologie
Medical oncologist
Medical Oncology
Medical Oncology (digestive cancers, lung cancers and brain tumors)
Medical Oncology Department
N/A
NA
nuclear medecine
Nuclear Medicine
onco
oncolgy
Oncologie
Oncologie médicale
Oncologie Radiothérapie
Oncologue
Oncologue médicale
Oncology
Oncology department
Oncology Médicale
Radiation Therapy
Radiation therapy department
Radiothérapie
Radiotherapy
Radiotherapy Department
Radiotherapy for pediatrics
Service d Oncologie Medicale
service d'conologie
Service d'Oncologie
Service d'oncologie médicale
Service d'Oncologie Medicale 3ème etage
Service d’Oncologie Médicale
Service de médecine nucléaire
Service de pneumologie
Service de radiothérapie
Service Oncologie
Service Oncologie Médicale
Service Radiothérapie
surgery
UF Oncologie
Unité de Phase Précoce
Unité de phases précoces U2P
Unité Fonctionnelle Oncologie

Clinical trials at this site (351)

Search interface

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given with Either Cemiplimab, or Cemiplimab + Fianlimab, … Recruiting

2022-501904-83-00 Ovarian Cancer 7 2023-09-11
A prospective program aiming at improving outcome for young adults with poor-prognosis non seminomatous germ-cell tumors (VAPOR (GETUG T06)) Recruiting

2023-505040-19-00 Non-seminomatous germ-cell tumors (including testis, re 4 2023-04-11
TRAK-ER_A randomised trial of early detection of molecular relapse with circulating tumour DNA tracking and treatment with palbociclib plus … Recruiting

2024-517414-15-00 ER positive HER2 negative breast cancer 4 2023-01-25
A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting

2024-514180-25-00 unresectable or metastatic HER2+ colorectal cancer 5 2022-11-21
TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b… Recruiting

2022-500643-20-00 Patients with locally advanced, metastatic or unresecta 4 2022-09-27
A phase II-III randomized trial evaluating maintenance pembrolizumab (± pemetrexed) until progression versus observation (± pemetrexed) afte… Recruiting

2024-515945-40-00 Non small cell lung cancer 10 2022-05-02
PEMBROCABOSARC : Combination of pembrolizumab and cabozantinib in patients with advanced sarcomas Recruiting

2023-509496-16-00 Advanced /metastatic sarcomas: undifferentiated pleomor 4 2022-04-21
Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Rectum cancer 10 2022-02-03
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients Recruiting

2023-508594-84-00 Metastatic pancreatic adenocarcinoma 4 2022-01-11
A study to investigate the safety and tolerability of Trastuzumab Deruxtecan in combination with Immunotherapy Agents with and without chemo… Recruiting

2023-504949-31-00 Advanced or metastatic non-squamous non-small lung canc 3 2021-12-01
Multicentric non-randomized phase II of pembrolizumab in combination with etoposide-cisplatin-based chemotherapy in first-line small cell ov… Recruiting

2024-515310-40-01 Patients with a confirmed diagnosis of ovarian small ce 4 2021-08-04
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 local advenced pancreatic adenocarcinoma 4 2021-06-17
Phase 2, Open label Study of Patritumab Deruxtecan (U3-1402), an Anti-HER3-Antibody Drug Conjugate (ADC), in patients with Advanced Breast C… Recruiting

2023-505923-30-00 Patients with hormone-receptor positive (HR+) and human 4 2021-05-11
AGADIR : Atezolizumab combined with EIK10001 (BDB001) and Immunogenic Radiotherapy in Patients with Advanced Solid Tumors Recruiting

2023-509492-16-00 Adult participants with metastatic (advanced) solid tum 4 2021-03-30
A clinical trial investigating the safety, tolerability, and therapeutic effects of BNT113 in combination with pembrolizumab versus pembroli… Recruiting

2024-512671-12-00 Unresectable head and neck squamous cell carcinoma, met 10 2021-03-05
RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine (REPAIR … Recruiting

2022-502642-27-00 RElapse in previously irradiated Prostate bed 9 2020-11-26
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other… Recruiting

2024-510783-23-00 Fallopian Tube Cancer 7 2020-10-29
Interest of peri operative CHemotherapy In patients with CINSARC highrisk localized Soft Tissue Sarcoma. Recruiting

2024-515384-62-00 Soft Tissue Sarcoma 5 2020-10-09
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine ad… Recruiting

2024-514603-34-00 intermediate-risk differentiated thyroid cancer patient 5 2020-03-02
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-00… Recruiting

2024-512606-25-00 Advanced Solid Tumors 7 2019-12-20